Cerity Partners LLC boosted its position in shares of Cigna Group (NYSE:CI - Free Report) by 1.0% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 94,146 shares of the health services provider's stock after buying an additional 916 shares during the quarter. Cerity Partners LLC's holdings in Cigna Group were worth $30,974,000 at the end of the most recent quarter.
Several other large investors have also bought and sold shares of CI. TCTC Holdings LLC acquired a new position in shares of Cigna Group in the 4th quarter valued at $25,000. Putney Financial Group LLC acquired a new stake in Cigna Group during the 4th quarter worth about $36,000. Transce3nd LLC acquired a new stake in Cigna Group during the 4th quarter worth about $38,000. Wayfinding Financial LLC acquired a new stake in Cigna Group during the 1st quarter worth about $40,000. Finally, Ameriflex Group Inc. acquired a new stake in Cigna Group during the 4th quarter worth about $44,000. Institutional investors own 86.99% of the company's stock.
Wall Street Analyst Weigh In
A number of brokerages have commented on CI. Morgan Stanley raised their price objective on Cigna Group from $379.00 to $390.00 and gave the stock an "overweight" rating in a research report on Monday, May 5th. TD Cowen raised Cigna Group to a "strong-buy" rating in a research note on Monday, June 23rd. Cowen reaffirmed a "buy" rating on shares of Cigna Group in a research note on Monday, May 5th. Royal Bank Of Canada reaffirmed an "outperform" rating and set a $371.00 price target on shares of Cigna Group in a research note on Thursday, June 26th. Finally, Piper Sandler raised their price target on Cigna Group from $348.00 to $374.00 and gave the stock an "overweight" rating in a research note on Monday, May 5th. Two research analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and three have given a strong buy rating to the stock. According to data from MarketBeat, Cigna Group currently has a consensus rating of "Buy" and a consensus price target of $380.39.
Get Our Latest Research Report on Cigna Group
Cigna Group Price Performance
CI traded down $1.17 during midday trading on Monday, reaching $302.11. 134,098 shares of the company's stock were exchanged, compared to its average volume of 1,818,101. The company has a quick ratio of 0.72, a current ratio of 0.72 and a debt-to-equity ratio of 0.65. The business has a 50-day simple moving average of $317.02 and a two-hundred day simple moving average of $310.83. The firm has a market capitalization of $80.70 billion, a price-to-earnings ratio of 16.73, a price-to-earnings-growth ratio of 0.90 and a beta of 0.44. Cigna Group has a one year low of $262.03 and a one year high of $370.83.
Cigna Group (NYSE:CI - Get Free Report) last posted its earnings results on Friday, May 2nd. The health services provider reported $6.74 EPS for the quarter, topping the consensus estimate of $6.35 by $0.39. Cigna Group had a return on equity of 18.63% and a net margin of 1.97%. The business had revenue of $65.45 billion during the quarter, compared to the consensus estimate of $60.39 billion. During the same quarter last year, the company earned $6.47 EPS. Cigna Group's revenue was up 14.4% on a year-over-year basis. As a group, research analysts predict that Cigna Group will post 29.77 EPS for the current year.
Cigna Group Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, June 18th. Shareholders of record on Tuesday, June 3rd were issued a dividend of $1.51 per share. The ex-dividend date of this dividend was Tuesday, June 3rd. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.00%. Cigna Group's payout ratio is presently 33.44%.
Cigna Group Profile
(
Free Report)
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
See Also

Before you consider Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.
While Cigna Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.